Literature DB >> 3117234

Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

C Pedersen1, C M Nielsen, B F Vestergaard, J Gerstoft, K Krogsgaard, J O Nielsen.   

Abstract

A total of 276 sequential serum samples from 34 men with antibodies to the human immunodeficiency virus (HIV) followed up for two to seven years were analysed for HIV antigen and antibodies to the viral core and envelope proteins. Results were correlated with clinical outcome and CD4 T lymphocyte count. Both antigenaemia and the disappearance of antibodies to the core protein were associated with development of the acquired immune deficiency syndrome (AIDS) or AIDS related complex and depletion of CD4 cells. Thus AIDS or AIDS related complex developed in eight out of 16 patients with antigenaemia compared with one out of 18 patients without antigenaemia. Low counts of CD4 cells (less than 0.5 X 10(9)/l) were found in 14 of the 16 patients with antigenaemia and five of the 18 without antigenaemia. Nine patients seroconverted to HIV during the study; two of these developed antigenaemia 14 and 16 months after the estimated time of seroconversion. These results show that the late stages of HIV infection are characterised by increased production of antigen and a decrease in antibodies directed against the core protein. Antigenaemia indicates a poor prognosis; and as the antigen test is simple to do and interpret, it may therefore be useful for selecting patients for antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117234      PMCID: PMC1248741          DOI: 10.1136/bmj.295.6598.567

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.

Authors:  J Goudsmit; J M Lange; D A Paul; G J Dawson
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

3.  Detection of HIV antigens in eluates from whole blood collected on filterpaper.

Authors:  C M Nielsen; I C Bygbjerg; B F Vestergaard
Journal:  Lancet       Date:  1987-03-07       Impact factor: 79.321

4.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

Authors:  J M Lange; R A Coutinho; W J Krone; L F Verdonck; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

5.  Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.

Authors:  V S Kalyanaraman; C D Cabradilla; J P Getchell; R Narayanan; E H Braff; J C Chermann; F Barré-Sinoussi; L Montagnier; T J Spira; J Kaplan
Journal:  Science       Date:  1984-07-20       Impact factor: 47.728

6.  Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS).

Authors:  R J Biggar; M Melbye; P Ebbesen; S Alexander; J O Nielsen; P Sarin; V Faber
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-12

7.  Severe acquired immunodeficiency in European homosexual men.

Authors:  J Gerstoft; A Malchow-Møller; I Bygbjerg; E Dickmeiss; C Enk; P Halberg; S Haahr; M Jacobsen; K Jensen; J Mejer; J O Nielsen; H K Thomsen; J Søndergaard; I Lorenzen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

8.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

Authors:  J Goudsmit; F de Wolf; D A Paul; L G Epstein; J M Lange; W J Krone; H Speelman; E C Wolters; J Van der Noordaa; J M Oleske
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321

9.  Laboratory testing on cerebrospinal fluid. A reappraisal.

Authors:  R A Hayward; M F Shapiro; R K Oye
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

10.  Immunological studies in homosexual men with and without antibodies to human T-cell lymphotropic virus type III.

Authors:  C Pedersen; P Kolby; J H Sindrup; M Arendrup; H C Wulf; J Gaub; J Gerstoft; B O Lindhardt
Journal:  Dan Med Bull       Date:  1986-10
View more
  35 in total

1.  An AIDS model with distributed incubation and variable infectiousness: applications to i.v. drug users in Latium, Italy.

Authors:  M Iannelli; R Loro; F Milner; A Pugliese; G Rabbiolo
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

2.  Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.

Authors:  L Zamora; J M Gatell; J M Barrera; G Ercilla; C Gil; E Buira; J M Miro; E Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

3.  HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.

Authors:  J W Mulder; P Krijnen; J Goudsmit; J K Schattenkerk; P Reiss; J M Lange
Journal:  Genitourin Med       Date:  1990-06

4.  Consensus on HIV testing.

Authors:  J Marks; H Curtis
Journal:  BMJ       Date:  1988-08-13

Review 5.  Heterosexual transmission of human immunodeficiency virus.

Authors:  A M Johnson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

6.  BETA-2-MICROGLOBULIN LEVELS IN HUMAN-IMMUNODEFICIENCY VIRUS INFECTED SUBJECTS.

Authors:  Mkk Rao; S K Sayal; S S Uppal; R M Gupta; V C Ohri; S Banerjee
Journal:  Med J Armed Forces India       Date:  2017-06-26

7.  Immunologic abnormalities related to antigenaemia during HIV-1 infection.

Authors:  P De Paoli; S Battistin; M Crovatto; M L Modolo; A Carbone; U Tirelli; G Santini
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

8.  Analysis of ovine lentivirus infectivity and replication by using a focal immunoassay and an antigen-capture enzyme-linked immunosorbent assay.

Authors:  K A Marcom; S J Brodie; L D Pearson; J C DeMartini
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  Host-virus interaction as defined by amplification of viral DNA and serology in lentivirus-infected sheep.

Authors:  S J Brodie; L D Pearson; G D Snowder; J C DeMartini
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Six strains of human immunodeficiency virus type 1 isolated in Japan and their molecular phylogeny.

Authors:  N Shimizu; Y Takeuchi; T Naruse; M Inagaki; E Moriyama; T Gojobori; H Hoshino
Journal:  J Mol Evol       Date:  1992-10       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.